ISSN 1673-3770 CN 37-1437/R
山东大学耳鼻喉眼学报 ›› 2022, Vol. 36 ›› Issue (2): 126-132.doi: 10.6040/j.issn.1673-3770.0.2022.011
韩莹莹，李延忠
HAN Yingying,LI Yanzhong
摘要： 阻塞性睡眠呼吸暂停低通气综合征是心血管疾病的独立危险因素,严重影响患者的生命质量和生存时间,也是可以改变的心血管疾病危险因素之一。动脉粥样硬化是造成心血管疾病的病理基础,而大量研究发现阻塞性睡眠呼吸暂停低通气综合征与亚临床动脉粥样硬化相关,综述阻塞性睡眠呼吸暂停低通气综合征与亚临床动脉粥样硬化的研究进展,并梳理其中发病机制,为阻塞性睡眠呼吸暂停低通气综合征患者动脉粥样硬化的预防和早期干预提供依据。
中图分类号:
| [1] Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences[J]. J Am Coll Cardiol, 2017, 69(7): 841-858. doi:10.1016/j.jacc.2016.11.069. [2] Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review[J]. JAMA, 2020, 323(14): 1389-1400. doi:10.1001/jama.2020.3514. [3] Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J]. J Am Coll Cardiol, 2020, 76(25): 2982-3021. doi:10.1016/j.jacc.2020.11.010. [4] Song DM, Fang GQ, Mao SZ, et al. Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice[J]. Atherosclerosis, 2018, 270: 68-75. doi:10.1016/j.atherosclerosis.2018.01.027. [5] Fang GQ, Song DM, Ye XB, et al. Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-κB p50[J]. Am J Pathol, 2012, 181(5): 1530-1539. doi:10.1016/j.ajpath.2012.07.024. [6] Zhou M, Guo BL, Wang YG, et al. The association between obstructive sleep apnea and carotid intima-media thickness: a systematic review and meta-analysis[J]. Angiology, 2017, 68(7): 575-583. doi:10.1177/0003319716665985. [7] Zhao YY, Javaheri S, Wang R, et al. Associations between sleep apnea and subclinical carotid atherosclerosis: the multi-ethnic study of atherosclerosis[J]. Stroke, 2019, 50(12): 3340-3346. doi:10.1161/STROKEAHA.118.022184. [8] Souza SP, Santos RB, Santos IS, et al. Obstructive sleep apnea, sleep duration, and associated mediators with carotid intima-media thickness: the ELSA-Brasil study[J]. Arterioscler Thromb Vasc Biol, 2021, 41(4): 1549-1557. doi:10.1161/ATVBAHA.120.315644. [9] Sforza E, Boissier C, Martin MS, et al. Carotid artery atherosclerosis and sleep disordered breathing in healthy elderly subjects: the Synapse cohort[J]. Sleep Med, 2013, 14(1): 66-70. doi:10.1016/j.sleep.2012.08.016. [10] Ljunggren M, Lindberg E, Franklin KA, et al. Obstructive sleep apnea during rapid eye movement sleep is associated with early signs of atherosclerosis in women[J]. Sleep, 2018, 41(7). doi:10.1093/sleep/zsy099. [11] Chen LD, Lin L, Lin XJ, et al. Effect of continuous positive airway pressure on carotid intima-media thickness in patients with obstructive sleep apnea: a meta-analysis[J]. PLoS One, 2017, 12(9): e0184293. doi:10.1371/journal.pone.0184293. [12] Biswas M, Saba LC, Omerzu T, et al. A review on joint carotid intima-media thickness and plaque area measurement in ultrasound for cardiovascular/stroke risk monitoring: artificial intelligence framework[J]. J Digit Imaging, 2021, 34(3): 581-604. doi:10.1007/s10278-021-00461-2. [13] Willeit P, Tschiderer L, Allara E, et al. Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100 667 patients[J]. Circulation, 2020, 142(7): 621-642. doi:10.1161/CIRCULATIONAHA.120.046361. [14] O'Leary DH, Bots ML. Imaging of atherosclerosis: carotid intima-media thickness[J]. Eur Heart J, 2010, 31(14): 1682-1689. doi:10.1093/eurheartj/ehq185. [15] Somers VK, Dyken ME, Mark AL, et al. Sympathetic-nerve activity during sleep in normal subjects[J]. N Engl J Med, 1993, 328(5): 303-307. doi:10.1056/nejm199302043280502. [16] Gilmartin GS, Lynch M, Tamisier R, et al. Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity[J]. Am J Physiol Heart Circ Physiol, 2010, 299(3): H925-H931. doi:10.1152/ajpheart.00253.2009. [17] Imadojemu VA, Mawji Z, Kunselman A, et al. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy[J]. Chest, 2007, 131(5): 1406-1413. doi:10.1378/chest.06-2580. [18] Imadojemu V, Gleeson K, Quraishi S, et al. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy[J]. Am J Respir Crit Care Med, 2002, 165(7): 950-953. doi:10.1164/ajrccm.165.7.2102003. [19] Sayk F, Teckentrup C, Becker C, et al. Effects of selective slow-wave sleep deprivation on nocturnal blood pressure dipping and daytime blood pressure regulation[J]. Am J Physiol Regul Integr Comp Physiol, 2010, 298(1): R191-R197. doi:10.1152/ajpregu.00368.2009. [20] Somers VK, Dyken ME, Skinner JL. Autonomic and hemodynamic responses and interactions during the Mueller maneuver in humans[J]. J Auton Nerv Syst, 1993, 44(2/3): 253-259. doi:10.1016/0165-1838(93)90038-v. [21] Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea[J]. Nat Rev Cardiol, 2010, 7(12): 677-685. doi:10.1038/nrcardio.2010.145. [22] Jelic S, le Jemtel TH. Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea[J]. Trends Cardiovasc Med, 2008, 18(7): 253-260. doi:10.1016/j.tcm.2008.11.008. [23] Cross MD, Mills NL, Al-Abri M, et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial[J]. Thorax, 2008, 63(7): 578-583. doi:10.1136/thx.2007.081877. [24] Knutson AK, Williams AL, Boisvert WA, et al. HIF in the heart: development, metabolism, ischemia, and atherosclerosis[J]. J Clin Invest, 2021, 131(17): e137557. doi:10.1172/JCI137557. [25] Chang YT, Lin HC, Chang WN, et al. Impact of inflammation and oxidative stress on carotid intima-media thickness in obstructive sleep apnea patients without metabolic syndrome[J]. J Sleep Res, 2017, 26(2): 151-158. doi:10.1111/jsr.12477. [26] Sofer T, Li RT, Joehanes R, et al. Low oxygen saturation during sleep reduces CD1D and RAB20 expressions that are reversed by CPAP therapy[J]. EBioMedicine, 2020, 56: 102803. doi:10.1016/j.ebiom.2020.102803. [27] Deeb R, Smeds MR, Bath J, et al. Snoring and carotid artery disease: a new risk factor emerges[J]. Laryngoscope, 2019, 129(1): 265-268. doi:10.1002/lary.27314. [28] Amatoury J, Howitt L, Wheatley JR, et al. Snoring-related energy transmission to the carotid artery in rabbits[J]. J Appl Physiol(1985), 2006, 100(5): 1547-1553. doi:10.1152/japplphysiol.01439.2005. [29] Chuang HH, Liu CH, Wang CY, et al. Snoring sound characteristics are associated with common carotid artery profiles in patients with obstructive sleep apnea[J]. Nat Sci Sleep, 2021,13: 1243-1255. doi:10.2147/NSS.S311125. [30] Floras JS. Sleep apnea and cardiovascular risk[J]. J Cardiol, 2014, 63(1): 3-8. doi:10.1016/j.jjcc.2013.08.009. [31] Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American heart association[J]. Circulation, 2021, 144(3): e56-e67. doi:10.1161/CIR.0000000000000988. [32] Koskinen J, Juonala M, Dwyer T, et al. Impact of lipid measurements in youth in addition to conventional clinic-based risk factors on predicting preclinical atherosclerosis in adulthood: international childhood cardiovascular cohort consortium[J]. Circulation, 2018, 137(12): 1246-1255. doi:10.1161/CIRCULATIONAHA.117.029726. [33] Raposeiras-Roubin S, Rosselló X, Oliva B, et al. Triglycerides and residual atherosclerotic risk[J]. J Am Coll Cardiol, 2021, 77(24): 3031-3041. doi:10.1016/j.jacc.2021.04.059. [34] Edgar L, Akbar N, Braithwaite AT, et al. Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis[J]. Circulation, 2021, 144(12): 961-982. doi:10.1161/CIRCULATIONAHA.120.046464. [35] Aggoun Y, Farpour-Lambert NJ, Marchand LM, et al. Impaired endothelial and smooth muscle functions and arterial stiffness appear before puberty in obese children and are associated with elevated ambulatory blood pressure[J]. Eur Heart J, 2008, 29(6): 792-799. doi:10.1093/eurheartj/ehm633. [36] Muxfeldt ES. Prevalence of obstructive sleep apnea in refractory hypertension[J]. Hypertension, 2018, 72(3): 592-593. doi:10.1161/hypertensionaha.118.11275. [37] Gunduz C, Basoglu OK, Hedner J, et al. Hyperlipidaemia prevalence and cholesterol control in obstructive sleep apnoea: data from the European sleep apnea database(ESADA)[J]. J Intern Med, 2019, 286(6): 676-688. doi:10.1111/joim.12952. [38] Anothaisintawee T, Reutrakul S, van Cauter E, et al. Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis[J]. Sleep Med Rev, 2016, 30: 11-24. doi:10.1016/j.smrv.2015.10.002. [39] Kim J, Mohler ER, Keenan BT, et al. Carotid artery wall thickness in obese and nonobese adults with obstructive sleep apnea before and following positive airway pressure treatment[J]. Sleep, 2017, 40(9): zsx126. doi:10.1093/sleep/zsx126. [40] Theodoropoulos K, Lykouras D, Karkoulias K, et al. Association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease[J]. Eur Rev Med Pharmacol Sci, 2017, 21(7): 1568-1575. PMID: 28429349. [41] Hao ZL, Qin L, Tong JY, et al. The differences of carotid atherosclerosis among non-OSAHS and OSAHS patients of different severities: a cross-sectional study[J]. Sleep Breath, 2021, 25(2): 639-648. doi:10.1007/s11325-020-02145-7. [42] Argyris AA, Mouziouras D, Samara S, et al. Superiority of 24-hour aortic over 24-hour brachial pressure to associate with carotid arterial damage on the basis of pressure amplification variability: the SAFAR study[J]. Hypertension, 2022, 79(3): 648-658. doi:10.1161/hypertensionaha.121.17906. [43] Kario K, Hettrick DA, Prejbisz A, et al. Obstructive sleep apnea-induced neurogenic nocturnal hypertension: a potential role of renal denervation? [J]. Hypertension, 2021, 77(4): 1047-1060. doi:10.1161/HYPERTENSIONAHA.120.16378. [44] Oscullo G, Sapiña-Beltrán E, Torres G, et al. The potential role of obstructive sleep apnoea in refractory hypertension[J]. Curr Hypertens Rep, 2019, 21(8): 57. doi:10.1007/s11906-019-0963-6. [45] Drager LF, Bortolotto LA, Krieger EM, et al. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis[J]. Hypertension, 2009, 53(1): 64-69. doi:10.1161/HYPERTENSIONAHA.108.119420. [46] Somuncu MU, Karakurt ST, Karakurt H, et al. The additive effects of OSA and nondipping status on early markers of subclinical atherosclerosis in normotensive patients: a cross-sectional study[J]. Hypertens Res, 2019, 42(2): 195-203. doi:10.1038/s41440-018-0143-0. [47] He LR, Liao X, Zhu GF, et al. miR-126a-3p targets HIF-1α and alleviates obstructive sleep apnea syndrome with hypertension[J]. Hum Cell, 2020, 33(4): 1036-1045. doi:10.1007/s13577-020-00404-z. [48] Tokgozoglu L, Orringer C, Ginsberg HN, et al. The year in cardiovascular medicine 2021: dyslipidaemia[J]. Eur Heart J, 2022, 43(8): 807-817. doi:10.1093/eurheartj/ehab875. [49] Drager LF, Tavoni TM, Silva VM, et al. Obstructive sleep apnea and effects of continuous positive airway pressure on triglyceride-rich lipoprotein metabolism[J]. J Lipid Res, 2018, 59(6): 1027-1033. doi:10.1194/jlr.M083436. [50] Simon, B, Barta I, Gabor B, et al. Effect of 5-year continuous positive airway pressure treatment on MMPs and TIMPs: implications for OSA comorbidities[J]. Scientific reports, 2020. 10(1): 8609. doi:10.1038/s41598-020-65029-6. [51] Ntambi JM, Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism[J]. Prog Lipid Res, 2004, 43(2): 91-104. doi:10.1016/S0163-7827(03)00039-0. [52] Drager LF, Li JG, Shin MK, et al. Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea[J]. Eur Heart J, 2012, 33(6): 783-790. doi:10.1093/eurheartj/ehr097. [53] Li J, Thorne LN, Punjabi NM, et al. Intermittent hypoxia induces hyperlipidemia in lean mice[J]. Circ Res, 2005, 97(7): 698-706. doi:10.1161/01.res.0000183879.60089.a9. [54] Drager LF, Yao QL, Hernandez KL, et al. Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4[J]. Am J Respir Crit Care Med, 2013, 188(2): 240-248. doi:10.1164/rccm.201209-1688OC. [55] Tang JJ, Li GX, Liu ZG, et al. Danlou Tablet improves chronic intermittent hypoxia-induced dyslipidemia and arteriosclerosis by HIF-1 α-Angptl4 mRNA signaling pathway[J]. Chin J Integr Med, 2020. doi:10.1007/s11655-020-3255-8. [56] Rossello X, Raposeiras-Roubin S, Oliva B, et al. Glycated hemoglobin and subclinical atherosclerosis in people without diabetes[J]. J Am Coll Cardiol, 2021, 77(22): 2777-2791. doi:10.1016/j.jacc.2021.03.335. [57] Adderley NJ, Subramanian A, Toulis K, et al. Obstructive sleep apnea, a risk factor for cardiovascular and microvascular disease in patients with type 2 diabetes: findings from a population-based cohort study[J]. Diabetes Care, 2020, 43(8): 1868-1877. doi:10.2337/dc19-2116. [58] Pugliese G, Barrea L, Laudisio D, et al. Sleep apnea, obesity, and disturbed glucose homeostasis: epidemiologic evidence, biologic insights, and therapeutic strategies[J]. Curr Obes Rep, 2020, 9(1): 30-38. doi:10.1007/s13679-020-00369-y. [59] Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis[J]. Cell Metab, 2011, 14(5): 575-585. doi:10.1016/j.cmet.2011.07.015. [60] Perakakis N, Farr OM, Mantzoros CS. Leptin in leanness and obesity: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2021, 77(6): 745-760. doi:10.1016/j.jacc.2020.11.069. [61] Raman P, Khanal S. Leptin in atherosclerosis: focus on macrophages, endothelial and smooth muscle cells[J]. Int J Mol Sci, 2021, 22(11): 5446. doi:10.3390/ijms22115446. [62] Biddinger SB, Miyazaki M, Boucher J, et al. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c[J]. Diabetes, 2006, 55(7): 2032-2041. doi:10.2337/db05-0742. [63] Zhang SY, Dong YQ, Wang PC, et al. Adipocyte-derived lysophosphatidylcholine activates adipocyte and adipose tissue macrophage nod-like receptor protein 3 inflammasomes mediating homocysteine-induced insulin resistance[J]. EBioMedicine, 2018, 31: 202-216. doi:10.1016/j.ebiom.2018.04.022. [64] Ying W, Fu WX, Lee YS, et al. The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities[J]. Nat Rev Endocrinol, 2020, 16(2): 81-90. doi:10.1038/s41574-019-0286-3. |
| [1] | 刘一洁,卢秀珍,吴秋欣. 外泌体在眼病发病机制和诊疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 135-141. |
| [2] | 潘佳煜,张春林. 急性低频感音神经性听力下降病因及发病机制的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 126-131. |
| [3] | 吴玮,王磊,陈升,李连勇,王刚. 胃食管气道反流性疾病多学科研究及进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 1-14. |
| [4] | 王桂芳,李仁高,马青. H-UPPP联合低温等离子舌根射频消融术对OSAHS患者血氧饱和度及动脉血氧分压的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 49-54. |
| [5] | 胡婷婷,王越华. 阻塞性睡眠呼吸暂停与乳腺癌相关性研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 41-45. |
| [6] | 王磊,李保卫,王刚,刘红丹,韩浩伦,张晓丽,吴玮. 阻塞性睡眠呼吸暂停低通气综合征患者夜间碱反流初步研究[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 75-79. |
| [7] | 袁钰淇,曹子讷,牛晓欣,谢雨杉,苏永龙,朱思敏,张一彤,刘海琴,任晓勇,施叶雯. 外周血炎症指标在阻塞性睡眠呼吸暂停低通气综合征伴高血压中的临床意义[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 85-92. |
| [8] | 邢亮,袁钰淇,谢雨杉,苏永龙,牛晓欣,麻莉娜,王子桐,刘海琴,施叶雯,任晓勇. 不同觉醒阈值阻塞性睡眠呼吸暂停低通气患者对血气、糖脂代谢水平的影响[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 106-111. |
| [9] | 丁龙庆,刘漪鸣,程卓,孙冉,梁辉. 口咽运动治疗成人阻塞性睡眠呼吸暂停低通气综合征的疗效初步观察[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 153-158. |
| [10] | 陈倬诣,郑亿庆,杨海弟. 慢性主观性耳鸣分类、发生发展机制及治疗新进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(4): 1-12. |
| [11] | 张红,李欣. 中枢神经系统活动异常在耳鸣发生中的作用与机制[J]. 山东大学耳鼻喉眼学报, 2023, 37(4): 24-29. |
| [12] | 陈尚丽,秦涛,陈璇,陈若瑾,唐智. Hcy及其代谢关键酶MTHFR C677T基因多态性与OSAHS患者高血压的相关性研究[J]. 山东大学耳鼻喉眼学报, 2023, 37(4): 126-133. |
| [13] | 李璐,赵杰,赵博军. 中心性浆液性脉络膜视网膜病变的发病机制与治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 118-124. |
| [14] | 李卓君,宋西成,陈秀梅. 阻塞性睡眠呼吸暂停低通气综合征患者的肺功能变化分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 45-50. |
| [15] | 王楠,黄晶,彭涛,冯勃. OSAHS与耳鸣的相关性研究现状[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 122-127. |
|
||